Invention Grant
- Patent Title: Isoxazole hydroxamic acid compounds as LpxC inhibitors
-
Application No.: US15728351Application Date: 2017-10-09
-
Publication No.: US10029994B2Publication Date: 2018-07-24
- Inventor: Jiping Fu , Xianming Jin , Subramanian Karur , Guillaume Lapointe , Ann Marie Madera , Zachary Kevin Sweeney
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Mark H. Hopkins
- Main IPC: C07D261/08
- IPC: C07D261/08 ; C07D413/12 ; C07D413/06 ; A61K31/422 ; A61K45/06 ; A61K31/42

Abstract:
This invention pertains generally to compounds of Formula I as described herein and compositions containing such compounds, as well as methods of using such compounds to treat bacterial infections. In certain aspects, the invention provides methods and compositions comprising these compounds for treating infections caused by Gram-negative bacteria.
Public/Granted literature
- US20180030004A1 ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS Public/Granted day:2018-02-01
Information query